Replisome dysfunction upon inducible TIMELESS degradation synergizes with ATR inhibition to trigger replication catastrophe.
Jinal A PatelCamryn ZezelicJulie RageulJoanne SaldanhaArafat KhanHyungjin KimPublished in: Nucleic acids research (2023)
The structure of DNA replication forks is preserved by TIMELESS (TIM) in the fork protection complex (FPC) to support seamless fork progression. While the scaffolding role of the FPC to couple the replisome activity is much appreciated, the detailed mechanism whereby inherent replication fork damage is sensed and counteracted during DNA replication remains largely elusive. Here, we implemented an auxin-based degron system that rapidly triggers inducible proteolysis of TIM as a source of endogenous DNA replication stress and replisome dysfunction to dissect the signaling events that unfold at stalled forks. We demonstrate that acute TIM degradation activates the ATR-CHK1 checkpoint, whose inhibition culminates in replication catastrophe by single-stranded DNA accumulation and RPA exhaustion. Mechanistically, unrestrained replisome uncoupling, excessive origin firing, and aberrant reversed fork processing account for the synergistic fork instability. Simultaneous TIM loss and ATR inactivation triggers DNA-PK-dependent CHK1 activation, which is unexpectedly necessary for promoting fork breakage by MRE11 and catastrophic cell death. We propose that acute replisome dysfunction results in a hyper-dependency on ATR to activate local and global fork stabilization mechanisms to counteract irreversible fork collapse. Our study identifies TIM as a point of replication vulnerability in cancer that can be exploited with ATR inhibitors.
Keyphrases
- dna damage response
- cell death
- oxidative stress
- liver failure
- dna damage
- respiratory failure
- drug induced
- single molecule
- circulating tumor
- climate change
- dna repair
- drug delivery
- dna methylation
- gene expression
- aortic dissection
- cell proliferation
- physical activity
- signaling pathway
- stress induced
- weight loss
- hepatitis b virus
- extracorporeal membrane oxygenation
- cancer therapy
- genome wide